tiprankstipranks
Trending News
More News >
Mesoblast Limited (AU:MSB)
ASX:MSB

Compare Mesoblast Limited (MSB) vs. Competitors

Compare
302 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mesoblast Limited
AU$2.53
AU$3.26B
-19.37
-17.32%
3 Buy
0 Hold
0 Sell
Strong Buy
Clinuvel Pharmaceuticals
AU$11.08
AU$552.21M
15.57
-9.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Neuren Pharmaceuticals Limited
AU$16.69
AU$2.11B
14.29
15.50%
5 Buy
0 Hold
0 Sell
Strong Buy
Orthocell Ltd
AU$0.92
AU$249.60M
-25.63
-37.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Immutep Ltd
AU$0.26
AU$582.12M
-9.36
12.86%
3 Buy
0 Hold
0 Sell
Strong Buy
Prescient Therapeutics Limited
AU$0.08
AU$73.61M
-7.69
29.63%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:MSB
Mesoblast Limited
2.53
-0.61
-19.43%
AU:CUV
Clinuvel Pharmaceuticals
11.00
-0.35
-3.04%
AU:NEU
Neuren Pharmaceuticals Limited
16.69
3.02
22.09%
AU:OCC
Orthocell Ltd
0.92
-0.55
-37.41%
AU:IMM
Immutep Ltd
0.40
0.08
23.44%
AU:PTX
Prescient Therapeutics Limited
0.07
0.02
40.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts